Actively Recruiting
Elevated Rate Pacing of Cardiac Amyloidosis
Led by University of Minnesota · Updated on 2026-05-13
10
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to better quantify the improvements in heart failure symptoms and exercise tolerance before and after the heart rate elevation in a cohort of 10 cardiac amyloidosis patients with preexisting pacemakers.
CONDITIONS
Official Title
Elevated Rate Pacing of Cardiac Amyloidosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults 18 years and older
- Diagnosis of cardiac amyloidosis according to recognized guidelines
- Implanted cardiac pacemaker or defibrillator
- Pacemaker mode of AAI or DDD if in sinus rhythm, VVI acceptable if permanent atrial fibrillation
- Non-dilated left ventricle seen on echocardiography
- Ability to provide written consent
- English speaking
You will not qualify if you...
- Paced QRS duration greater than 150 ms indicating pacing mediated dyssynchrony
- Dilated left ventricle
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Minnesota
Minneapolis, Minnesota, United States, 55455
Actively Recruiting
Research Team
M
Meghan Muscala
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here